BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29703840)

  • 1. Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development.
    Zook EC; Li ZY; Xu Y; de Pooter RF; Verykokakis M; Beaulieu A; Lasorella A; Maienschein-Cline M; Sun JC; Sigvardsson M; Kee BL
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29703840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ID2 and ID3 are indispensable for Th1 cell differentiation during influenza virus infection in mice.
    Han X; Liu H; Huang H; Liu X; Jia B; Gao GF; Zhang F
    Eur J Immunol; 2019 Mar; 49(3):476-489. PubMed ID: 30578645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity.
    Boos MD; Yokota Y; Eberl G; Kee BL
    J Exp Med; 2007 May; 204(5):1119-30. PubMed ID: 17452521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development.
    Schotte R; Dontje W; Nagasawa M; Yasuda Y; Bakker AQ; Spits H; Blom B
    J Immunol; 2010 Jun; 184(12):6670-9. PubMed ID: 20483740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cells.
    Rautela J; Dagley LF; Kratina T; Anthony A; Goh W; Surgenor E; Delconte RB; Webb AI; Elwood N; Groom JR; Souza-Fonseca-Guimaraes F; Corcoran L; Huntington ND
    Mol Immunol; 2019 Nov; 115():56-63. PubMed ID: 30144957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.
    Weiler S; Ademokun JA; Norton JD
    Mol Cancer; 2015 Feb; 14(1):30. PubMed ID: 25644253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets.
    Yang CY; Best JA; Knell J; Yang E; Sheridan AD; Jesionek AK; Li HS; Rivera RR; Lind KC; D'Cruz LM; Watowich SS; Murre C; Goldrath AW
    Nat Immunol; 2011 Nov; 12(12):1221-9. PubMed ID: 22057289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation.
    Masson F; Minnich M; Olshansky M; Bilic I; Mount AM; Kallies A; Speed TP; Busslinger M; Nutt SL; Belz GT
    J Immunol; 2013 May; 190(9):4585-94. PubMed ID: 23536629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion.
    Li J; Wu D; Jiang N; Zhuang Y
    J Immunol; 2013 Nov; 191(10):5052-64. PubMed ID: 24123680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells.
    Zhang B; Lin YY; Dai M; Zhuang Y
    J Immunol; 2014 Feb; 192(3):1055-1063. PubMed ID: 24379125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.
    Miyazaki M; Miyazaki K; Chen S; Itoi M; Miller M; Lu LF; Varki N; Chang AN; Broide DH; Murre C
    Nat Immunol; 2014 Aug; 15(8):767-76. PubMed ID: 24973820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15.
    Delconte RB; Shi W; Sathe P; Ushiki T; Seillet C; Minnich M; Kolesnik TB; Rankin LC; Mielke LA; Zhang JG; Busslinger M; Smyth MJ; Hutchinson DS; Nutt SL; Nicholson SE; Alexander WS; Corcoran LM; Vivier E; Belz GT; Carotta S; Huntington ND
    Immunity; 2016 Jan; 44(1):103-115. PubMed ID: 26795246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
    Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inhibitor of binding or differentiation 2 in the development and differentiation of immune cells.
    Wu H; Shao Q
    Immunobiology; 2019 Jan; 224(1):142-146. PubMed ID: 30340915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting gears: Id3 enables recruitment of E proteins to new targets during T cell development and differentiation.
    Anderson MK
    Front Immunol; 2022; 13():956156. PubMed ID: 35983064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.
    Fujimoto S; Ikawa T; Kina T; Yokota Y
    Int Immunol; 2007 Oct; 19(10):1175-82. PubMed ID: 17698981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E protein transcription factors are required for the development of CD4(+) lineage T cells.
    Jones-Mason ME; Zhao X; Kappes D; Lasorella A; Iavarone A; Zhuang Y
    Immunity; 2012 Mar; 36(3):348-61. PubMed ID: 22425249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transcriptional Regulator Id2 Is Critical for Adipose-Resident Regulatory T Cell Differentiation, Survival, and Function.
    Frias AB; Hyzny EJ; Buechel HM; Beppu LY; Xie B; Jurczak MJ; D'Cruz LM
    J Immunol; 2019 Aug; 203(3):658-664. PubMed ID: 31201238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.
    Li J; Roy S; Kim YM; Li S; Zhang B; Love C; Reddy A; Rajagopalan D; Dave S; Diehl AM; Zhuang Y
    J Immunol; 2017 Apr; 198(8):3136-3148. PubMed ID: 28258199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of E protein transcription factors E2A and HEB delays memory-precursor formation during the CD8+ T-cell immune response.
    D'Cruz LM; Lind KC; Wu BB; Fujimoto JK; Goldrath AW
    Eur J Immunol; 2012 Aug; 42(8):2031-41. PubMed ID: 22585759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.